Popular Trials
Behavioral Intervention
Physical Activity and Education for Colorectal Cancer
This trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.
Selective Serotonin Reuptake Inhibitor
Fluoxetine for Anxiety and Depression
This trial uses fMRI to study brain regions engaged in processing motivationally salient stimuli in children, adolescents, and adults with mood and anxiety disorders, in order to better understand how these disorders develop and how they can be treated.
Ultrasound Therapy
Focused Ultrasound Neuromodulation for Affective Disorders
This trial is testing a new treatment using sound waves to target a part of the brain in people with emotional disorders like depression and anxiety. The treatment aims to change how this part of the brain works to improve symptoms. It is non-invasive and uses MRI to monitor changes in the brain.
Behavioural Intervention
TEAMSS Program for Anxiety Disorders
This trial aims to develop and test a program called TEAMSS to help students with anxiety transition successfully to middle school. The program will focus on reducing anxiety and improving academic performance. The study will involve expert
Behavioural Intervention
Structured Games/Playgroup for Childhood Anxiety
This trial is testing if the Camp Kidpower training, which uses either structured games or a playgroup, can lower anxiety in preschool age children. The study will look at parts of the brain as well as behaviors related to effortful control and fear, before and after training, to see if Kidpower helps kids stay in charge of their behaviors and emotions.
Popular Filters
Trials for Social Anxiety Disorder Patients
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Behavioral Intervention
Cognitive Behavioural Skills Training for Anxiety Disorders
"This trial aims to test a new program that helps parents with anxiety disorders learn coping skills to prevent their children from developing anxiety disorders. The goal is to intervene early and help children lead happy and healthy lives
Trials for Obsessive-Compulsive Disorder Patients
Nonsteroidal Anti-inflammatory Drug
Naproxen Sodium for OCD in PANDAS
This trial tests Naproxen Sodium, an anti-inflammatory drug, to see if it can reduce OCD symptoms in children with PANDAS. These children have OCD symptoms linked to inflammation from streptococcal infections. The medication aims to lower inflammation, potentially easing their symptoms.
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Trials With No Placebo
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Behavioral Intervention
Cognitive Behavioural Skills Training for Anxiety Disorders
"This trial aims to test a new program that helps parents with anxiety disorders learn coping skills to prevent their children from developing anxiety disorders. The goal is to intervene early and help children lead happy and healthy lives
Personality-Targeted Interventions for Substance Abuse
This trial will help researchers understand if a personality-targeted intervention, in addition to regular treatment, can help reduce alcohol and illicit drug use in adolescents with mental health problems.
View More Related Trials
Frequently Asked Questions
Introduction to generalized anxiety disorder
What are the top hospitals conducting generalized anxiety disorder research?
When it comes to advancing the understanding and treatment of generalized anxiety disorder (GAD), several top hospitals are leading the way. In Boston, Massachusetts General Hospital is at the forefront with eight ongoing clinical trials dedicated to GAD. With a remarkable history of 31 completed trials since their first recorded investigation in 2003, this esteemed institution continues to push boundaries in anxiety research. Across the border in Toronto, Canada's own Toronto Western Hospital has two active GAD trials under its belt. Despite being relatively new to GAD research, having only started their first trial in 2023, this hospital is already making significant contributions.
Moving southwest to Cincinnati, Ohio, the University of Cincinnati is also actively involved in furthering our understanding of GAD through two ongoing clinical trials. Since embarking on their inaugural study in 2013, they have conducted three total trials on this complex condition. Similarly invested in combating GAD is Kingston Health Sciences Centre located in Kingston, Canada—another facility conducting two active clinical trials for GAD patients. Their journey into exploring treatment options for anxiety disorders began back in 2009 when they embarked on their first recorded trial.
Notably contributing from Houston, Texas is Baylor College of Medicine—an influential institution that currently has two active clinical trials targeting generalized anxiety disorder. Having initiated their first recorded trial over a decade ago in 2008 and completing eleven investigations overall since then shows unwavering dedication towards improving outcomes for individuals struggling with excessive worry and fear.
These notable hospitals serve as beacons of hope for those experiencing the debilitating effects of generalized anxiety disorder worldwide. Through cutting-edge research and innovative treatments provided by these institutions across different locations such as Boston or even internationally like Toronto; advancements are made every day towards alleviating symptoms while enhancing quality-of-life . With each study conducted comes an opportunity for breakthroughs that can revolutionize how we approach mental health challenges
Which are the best cities for generalized anxiety disorder clinical trials?
When it comes to clinical trials for generalized anxiety disorder, several cities are at the forefront of research and innovation. Boston, Massachusetts leads with 16 active trials investigating treatments like Cannabidiol, Buspirone, and QUIT. Houston, Texas follows closely behind with 8 ongoing studies focusing on interventions such as iTCBT-I and Cognitive Behavioral Teletherapy LTA. Los Angeles, California also plays a significant role in this field with 6 active trials exploring strategies like cognitive behavioral therapy combined with benzodiazepine tapering and medication options like Fluoxetine. These cities offer individuals struggling with generalized anxiety disorder access to cutting-edge clinical trials that may revolutionize treatment approaches and improve their quality of life.
Which are the top treatments for generalized anxiety disorder being explored in clinical trials?
Generalized anxiety disorder is a challenging condition, but clinical trials offer hope in exploring new treatments. Two top contenders are cannabidiol and buspirone. Cannabidiol, introduced in 2020, has been the focus of two active trials and is part of five all-time studies for generalized anxiety disorder. Buspirone, on the other hand, made its debut in 2011 and has also garnered attention with two ongoing trials and six total studies dedicated to tackling this condition. These innovative approaches bring potential relief to individuals grappling with generalized anxiety disorder as researchers strive to find effective solutions through rigorous scientific investigation.
What are the most recent clinical trials for generalized anxiety disorder?
Recent clinical trials offer hope for individuals suffering from generalized anxiety disorder. Inositol, a potential treatment for this condition, has shown promise in both Phase 1 and Phase 2 trials conducted as early as September 2023. Another study examined the effects of ABBV-932 specifically on generalized anxiety disorder patients during its Phase 1 trial, which became available in August 2023. Additionally, cannabidiol, a compound derived from cannabis plants, is being investigated in a Phase 4 trial that began in April 2023. Furthermore, endotoxin has been evaluated through a Phase 1 trial starting March 2023 to assess its impact on generalized anxiety disorder symptoms. Lastly, psychotherapy remains an important avenue of research with ongoing investigations into its effectiveness through a Phase 2 trial initiated in April 2022. With these advancements underway, there is renewed optimism for improved management and relief from the burdens of generalized anxiety disorder.
What generalized anxiety disorder clinical trials were recently completed?
Several noteworthy clinical trials for generalized anxiety disorder have recently concluded, signaling progress in the search for effective treatments. In May 2022, Receptor Life Sciences finished a trial investigating Low dose RLS103 as a potential therapeutic option. Similarly, Bionomics Limited completed their study on the efficacy of 225 mg BNC210 in February 2022. Another significant development came from VistaGen Therapeutics, Inc., which wrapped up their PH94B Nasal Spray trial in May 2021. These advancements shed light on ongoing efforts to address and manage generalized anxiety disorder, offering hope to individuals living with this condition.